L. Monnier, A. Zahar, J. Barbut, and F. , Update on Clostridium difficile infections, M??decine et Maladies Infectieuses, vol.44, issue.8, pp.354-65, 2014.
DOI : 10.1016/j.medmal.2014.04.002

C. Eckert, B. Coignard, M. Hebert, C. Tarnaud, C. Tessier et al., Clinical and microbiological features of Clostridium difficile infections in France: The ICD-RAISIN 2009 national survey, M??decine et Maladies Infectieuses, vol.43, issue.2, pp.67-74, 2013.
DOI : 10.1016/j.medmal.2013.01.004

M. Bauer, D. Notermans, B. Van-benthem, J. Brazier, M. Wilcox et al., Clostridium difficile infection in Europe: a hospital-based survey, The Lancet, vol.377, issue.9759, pp.63-73, 2011.
DOI : 10.1016/S0140-6736(10)61266-4

J. Pépin, L. Valiquette, M. Alary, P. Villemure, A. Pelletier et al., Clostridium difficileassociated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity Severe Clostridium difficile-associated disease in populations previously at low risk-four states, CMAJ. Centers for Disease Control and Prevention MMWR, vol.17154, issue.6, pp.1201-1206, 2004.

M. Crobach, O. Dekkers, M. Wilcox, and E. Kuijper, European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection (CDI), Clinical Microbiology and Infection, vol.15, issue.12, pp.1053-66, 2009.
DOI : 10.1111/j.1469-0691.2009.03098.x

S. Cohen, . Md, D. Gerding, S. Md, M. Johnson et al., Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA), Infection Control and Hospital Epidemiology, vol.31, issue.5, pp.431-55, 2010.
DOI : 10.1086/651706

S. Debast, M. Bauer, E. Kuijper, and C. , European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection, Clinical Microbiology and Infection, vol.20, pp.1-26, 2014.
DOI : 10.1111/1469-0691.12418

. Conduite-À-tenir, diagnostic, investigation, surveillance et principes de prévention et de maîtrise des infections à Clostridium difficile. Guide RAISIN, 2006.

V. Loo, A. Bourgault, L. Poirier, F. Lamothe, S. Michaud et al., Infection and Colonization, New England Journal of Medicine, vol.365, issue.18, pp.1693-703, 2011.
DOI : 10.1056/NEJMoa1012413

D. Gerding, ???Associated Diarrhea: This Is an Antimicrobial Resistance Problem, Clinical Infectious Diseases, vol.16, issue.5, pp.646-654, 2004.
DOI : 10.1093/jac/46.4.551

J. Pépin, N. Saheb, M. Coulombe, M. Alary, M. Corriveau et al., Emergence of Fluoroquinolones as the Predominant Risk Factor for Clostridium difficile-Associated Diarrhea: A Cohort Study during an Epidemic in Quebec, Clinical Infectious Diseases, vol.118, issue.3, pp.1254-60, 2005.
DOI : 10.1016/j.amjmed.2004.09.015

C. Thomas and T. Riley, Restriction of third generation cephalosporin use reduces the incidence of Clostridium difficile-associated diarrhoea in hospitalised patients, Commun Dis Intell Q Rep, vol.27, pp.28-31, 2003.

H. Autorité and D. Santé, Rapport d'élaboration de févier 2014 Rapport d'élaboration -principes généraux et conseils de prescription des antibiotiques en premiers recours

R. Koretz, infection, Annals of Internal Medicine, vol.157, issue.4, pp.2-13, 2012.
DOI : 10.7326/0003-4819-157-4-201208210-02013

C. Dechamp, Les IPP en EHPAD-l'expérience de l'EPHAD du Dr Chastaing à Limoges, 31ème Journées annuelles de la Société Française de Gériatrie et de Gérontologie, pp.4-6, 2011.

P. Kutty, S. Benoit, C. Woods, A. Sena, S. Naggie et al., Conclusions., Infection Control & Hospital Epidemiology, vol.29, issue.03, pp.197-202, 2008.
DOI : 10.1016/S0140-6736(00)03592-3

F. Barbut, B. Gariazzo, L. Bonné, V. Lalande, B. Burghoffer et al., Conclusion., Infection Control & Hospital Epidemiology, vol.37, issue.02, pp.131-140, 2007.
DOI : 10.1099/jmm.0.45610-0

L. Mcfarland, G. Elmer, and C. Surawicz, Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease, The American Journal of Gastroenterology, vol.78, issue.7, pp.1769-75, 2002.
DOI : 10.1128/IAI.69.4.2762-2765.2001

K. Garey, S. Sethi, Y. Yadav, and H. Dupont, Meta-analysis to assess risk factors for recurrent Clostridium difficile infection, Journal of Hospital Infection, vol.70, issue.4, pp.298-304, 2008.
DOI : 10.1016/j.jhin.2008.08.012

J. Pepin, M. Alary, L. Valiquette, E. Raiche, J. Ruel et al., Increasing Risk of Relapse after Treatment of Clostridium difficile Colitis in Quebec, Canada, Clinical Infectious Diseases, vol.171, issue.11, pp.1591-1598, 2005.
DOI : 10.1503/cmaj.1041694

L. Kyne, M. Warny, A. Qamar, and C. Kelly, Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea, The Lancet, vol.357, issue.9251, pp.189-93, 2001.
DOI : 10.1016/S0140-6736(00)03592-3

S. Péchiné, A. Gleizes, C. Janoir, R. Gorges-kergot, M. Barc et al., Immunological properties of surface proteins of Clostridium difficile, Journal of Medical Microbiology, vol.54, issue.2, pp.193-199, 2005.
DOI : 10.1099/jmm.0.45800-0

L. Guern, R. Wallet, and F. , Laboratory diagnosis of Clostridium difficile infection, Ann Biol Clin, vol.71, pp.395-400, 2013.

D. Tang, N. Urrunaga, D. Groot, H. Von-rosenvinge, E. Xie et al., Pseudomembranous colitis: Not always Clostridium difficile, Cleveland Clinic Journal of Medicine, vol.83, issue.5, pp.1-4, 2014.
DOI : 10.3949/ccjm.83a.14183

F. Zar, S. Bakkanagari, K. Moorthi, and M. Davis, A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease Severity, Clinical Infectious Diseases, vol.343, issue.26, pp.302-309, 2007.
DOI : 10.1056/NEJM200012283432604

S. Aslam, R. Hamill, and D. Musher, Treatment of Clostridium difficile-associated disease: old therapies and new strategies, The Lancet Infectious Diseases, vol.5, issue.9, pp.549-57, 2005.
DOI : 10.1016/S1473-3099(05)70215-2

D. Musher, S. Aslam, N. Logan, S. Nallacheru, I. Bhaila et al., Relatively Poor Outcome after Treatment of Clostridium difficile Colitis with Metronidazole, Clinical Infectious Diseases, vol.22, issue.3, pp.1586-90, 2005.
DOI : 10.1128/IAI.71.3.1608-1610.2003

M. Wilcox and R. Howe, : response time for treatment with metronidazole and vancomycin, Journal of Antimicrobial Chemotherapy, vol.36, issue.4, pp.673-682, 1995.
DOI : 10.1093/jac/36.4.673

O. Cornely, M. Miller, T. Louie, D. Crook, and S. Gorbach, Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin, Clinical Infectious Diseases, vol.52, issue.8, pp.154-61, 2012.
DOI : 10.1128/AAC.00342-08

B. Guo, C. Harstall, T. Louie, V. Van-zanten, S. Dieleman et al., Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease, Alimentary Pharmacology & Therapeutics, vol.45, issue.Suppl. 1, pp.865-75, 2012.
DOI : 10.1097/MCG.0b013e3182166c8b

I. Lowy, D. Molrine, B. Leav, B. Blair, R. Baxter et al., Toxins, New England Journal of Medicine, vol.362, issue.3, pp.197-205, 2010.
DOI : 10.1056/NEJMoa0907635

J. Goldenberg, S. Ma, J. Saxton, M. Martzen, P. Vandvik et al., Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children, Cochrane Database Syst Rev, vol.5, p.6095, 2013.

L. Mcfarland, C. Surawicz, R. Greenberg, R. Fekety, G. Elmer et al., A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease, JAMA, vol.271, 1994.

L. Beaugerie, A. Flahault, F. Barbut, P. Atlan, V. Lalande et al., Antibiotic-associated diarrhoea and Clostridium difficile> in the community, Alimentary Pharmacology and Therapeutics, vol.250, issue.7, pp.905-917, 2003.
DOI : 10.1016/S0140-6736(00)03592-3